Find Halofantrine Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 36167-63-2, Halfan, Halofantrine hcl, Halofantrine hydrochloride [usan], Wr-171669, Skf-102886
Molecular Formula
C26H31Cl3F3NO
Molecular Weight
536.9  g/mol
InChI Key
WANGFTDWOFGECH-UHFFFAOYSA-N
FDA UNII
H77DL0Y630

Halofantrine Hydrochloride
1 2D Structure

Halofantrine Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride
2.1.2 InChI
InChI=1S/C26H30Cl2F3NO.ClH/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23;/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3;1H
2.1.3 InChI Key
WANGFTDWOFGECH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O.Cl
2.2 Other Identifiers
2.2.1 UNII
H77DL0Y630
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol Hcl

2. Halfan

3. Halofantrine

4. Wr 171,699

5. Wr 171669

6. Wr-171,669

7. Wr-171699

2.3.2 Depositor-Supplied Synonyms

1. 36167-63-2

2. Halfan

3. Halofantrine Hcl

4. Halofantrine Hydrochloride [usan]

5. Wr-171669

6. Skf-102886

7. Halofantrine (hydrochloride)

8. 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride

9. (-)-halofantrine Hydrochloride

10. 2b7enl644k

11. 106927-11-1

12. Halofantrine Hydrochloride, (-)-

13. H77dl0y630

14. 3-(dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol Hydrochloride

15. 9-(3-(dibutylamino)-1-hydroxypropyl)-1,3-dichloro-6-(trifluoromethyl)phenanthrene Hydrochloride

16. Dl-wr 171669

17. Ncgc00016833-01

18. Skf-102886;wr-171669

19. Dsstox_cid_25464

20. Dsstox_rid_80895

21. Dsstox_gsid_45464

22. Halofantrine Hydrochloride (usan)

23. Halofantrino

24. Halofantrino [spanish]

25. Mls002154111

26. 66051-64-7

27. Cas-36167-63-2

28. (+-)-halofantrine Hydrochloride

29. Wr 171669

30. Wr-171,669

31. Smr001233418

32. Einecs 252-895-4

33. Unii-h77dl0y630

34. Halfan (tn)

35. Mfcd00879136

36. Skf 102886

37. Halofantrine Hydrochlorid

38. 1,3-dichloro-6-trifluoromethyl-9-(3-(dibutylamino)-1-hydroxypropyl)phenanthrene Hcl

39. 1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-(di-n-butylamino)propanol Hydrochloride

40. Unii-2b7enl644k

41. 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol Hydrochloride

42. Schembl466895

43. Chembl1200901

44. Dtxsid0045464

45. Hy-a0148a

46. Hms1571o03

47. Tox21_110637

48. Akos030254762

49. Tox21_110637_1

50. Ccg-221031

51. Halofantrine Hydrochloride [mi]

52. Sk&f-102866

53. Ncgc00179250-03

54. (+/-)-halofantrine Hydrochloride

55. 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)phenanthren-1-methanol Hydrochloride

56. 9-phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride

57. Halofantrine Hydrochloride [mart.]

58. Halofantrine Hydrochloride [vandf]

59. Halofantrine Hydrochloride [who-dd]

60. Cs-0031225

61. Ft-0600399

62. D02485

63. Halofantrine Hydrochloride [ep Impurity]

64. Halofantrine Hydrochloride [orange Book]

65. Halofantrine Hydrochloride [ep Monograph]

66. 167h632

67. Halofantrine Hydrochloride, >=98% (hplc), Solid

68. Sr-01000841216

69. Sr-01000841216-2

70. W-106636

71. Halofantrine Hydrochloride, European Pharmacopoeia (ep) Reference Standard

72. 1-[1,3-dichloro-6-trifluoromethyl-9-phenanthryl]-3-di(n-butyl)aminopropanol Hydrochloride

73. 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemethanol Hydrochloride

74. 1,3-dichloro-alpha-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrenemethanol;(+/-)-halofantrine Hydrochloride

75. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride

76. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride (1:1)

77. 9-phenanthrenemethanol, 1,3-dichloro-.alpha.-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride, (-)-

78. 9-phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, Hydrochloride, (-)-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 536.9 g/mol
Molecular Formula C26H31Cl3F3NO
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count10
Exact Mass535.142332 g/mol
Monoisotopic Mass535.142332 g/mol
Topological Polar Surface Area23.5 Ų
Heavy Atom Count34
Formal Charge0
Complexity584
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antimalarials

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)


REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Halofantrine Hydrochloride Manufacturers

A Halofantrine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Halofantrine Hydrochloride, including repackagers and relabelers. The FDA regulates Halofantrine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Halofantrine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Halofantrine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Halofantrine Hydrochloride Suppliers

A Halofantrine Hydrochloride supplier is an individual or a company that provides Halofantrine Hydrochloride active pharmaceutical ingredient (API) or Halofantrine Hydrochloride finished formulations upon request. The Halofantrine Hydrochloride suppliers may include Halofantrine Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Halofantrine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Halofantrine Hydrochloride NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Halofantrine Hydrochloride as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Halofantrine Hydrochloride API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Halofantrine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Halofantrine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Halofantrine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Halofantrine Hydrochloride suppliers with NDC on PharmaCompass.

Halofantrine Hydrochloride GMP

Halofantrine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Halofantrine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Halofantrine Hydrochloride GMP manufacturer or Halofantrine Hydrochloride GMP API supplier for your needs.

Halofantrine Hydrochloride CoA

A Halofantrine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Halofantrine Hydrochloride's compliance with Halofantrine Hydrochloride specifications and serves as a tool for batch-level quality control.

Halofantrine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Halofantrine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Halofantrine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Halofantrine Hydrochloride EP), Halofantrine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Halofantrine Hydrochloride USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty